
James William Rogers
Examiner (ID: 13796)
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1194 |
| Issued Applications | 502 |
| Pending Applications | 144 |
| Abandoned Applications | 586 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17836508
[patent_doc_number] => 20220273813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PHOTOSENSITIZER-CONJUGATED ANTIMICROBIAL CELLULOSE NANOCRYSTALS AND METHODS OF SYNTHESIZING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/638755
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638755 | PHOTOSENSITIZER-CONJUGATED ANTIMICROBIAL CELLULOSE NANOCRYSTALS AND METHODS OF SYNTHESIZING AND USING SAME | Aug 25, 2020 | Abandoned |
Array
(
[id] => 17768240
[patent_doc_number] => 11400159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Pharmaceutical compositions and related methods of delivery
[patent_app_type] => utility
[patent_app_number] => 16/990071
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28913
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990071
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990071 | Pharmaceutical compositions and related methods of delivery | Aug 10, 2020 | Issued |
Array
(
[id] => 18994670
[patent_doc_number] => 11911488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
[patent_app_type] => utility
[patent_app_number] => 16/984415
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 23622
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984415 | Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy | Aug 3, 2020 | Issued |
Array
(
[id] => 16581561
[patent_doc_number] => 20210015963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => RADIOPAQUE POLYMERS
[patent_app_type] => utility
[patent_app_number] => 16/933042
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/933042 | Radiopaque polymers | Jul 19, 2020 | Issued |
Array
(
[id] => 16389673
[patent_doc_number] => 20200330614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => Imaging Neurotransmitters In Vivo Using Functionalized Carbon Nanotubes
[patent_app_type] => utility
[patent_app_number] => 16/917915
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16917915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/917915 | Imaging neurotransmitters in vivo using functionalized carbon nanotubes | Jun 30, 2020 | Issued |
Array
(
[id] => 16474936
[patent_doc_number] => 10849856
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Melatonin mini-tablets and method of manufacturing the same
[patent_app_type] => utility
[patent_app_number] => 16/902425
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 7947
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902425 | Melatonin mini-tablets and method of manufacturing the same | Jun 15, 2020 | Issued |
Array
(
[id] => 16341577
[patent_doc_number] => 20200306227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => MELATONIN MINI-TABLETS AND METHOD OF MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/902419
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902419
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902419 | Melatonin mini-tablets and method of manufacturing the same | Jun 15, 2020 | Issued |
Array
(
[id] => 19324908
[patent_doc_number] => 12042561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Hydrophobic molecule-induced branched polymer aggregates and their use
[patent_app_type] => utility
[patent_app_number] => 16/900978
[patent_app_country] => US
[patent_app_date] => 2020-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 29
[patent_no_of_words] => 16109
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900978 | Hydrophobic molecule-induced branched polymer aggregates and their use | Jun 13, 2020 | Issued |
Array
(
[id] => 16876923
[patent_doc_number] => 11027043
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-08
[patent_title] => Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
[patent_app_type] => utility
[patent_app_number] => 16/894107
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 68445
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894107 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | Jun 4, 2020 | Issued |
Array
(
[id] => 17748308
[patent_doc_number] => 20220226511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => pH RESPONSIVE COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/614638
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614638 | pH RESPONSIVE COMPOSITIONS AND USES THEREOF | May 27, 2020 | Pending |
Array
(
[id] => 18449657
[patent_doc_number] => 20230190933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof
[patent_app_type] => utility
[patent_app_number] => 17/924931
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 412
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924931
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924931 | Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof | May 11, 2020 | Pending |
Array
(
[id] => 18449657
[patent_doc_number] => 20230190933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof
[patent_app_type] => utility
[patent_app_number] => 17/924931
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 412
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924931
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924931 | Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof | May 11, 2020 | Pending |
Array
(
[id] => 17685964
[patent_doc_number] => 20220193256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => NANO-ANTIBIOTICS BASED ON SINGLE-CHAIN DEXTRAN NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/604590
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604590 | NANO-ANTIBIOTICS BASED ON SINGLE-CHAIN DEXTRAN NANOPARTICLES | Apr 16, 2020 | Abandoned |
Array
(
[id] => 16221416
[patent_doc_number] => 20200246532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => Hemocompatibility Modifiers For Cross-Linked Polymeric Material
[patent_app_type] => utility
[patent_app_number] => 16/851305
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851305
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851305 | Hemocompatibility modifiers for cross-linked polymeric material | Apr 16, 2020 | Issued |
Array
(
[id] => 16204931
[patent_doc_number] => 20200237921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => METHOD FOR REMOVING ACETALDEHYDE
[patent_app_type] => utility
[patent_app_number] => 16/849881
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849881
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849881 | Method for removing acetaldehyde | Apr 14, 2020 | Issued |
Array
(
[id] => 19792245
[patent_doc_number] => 12233168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Localization of payload delivery systems to tumor sites via beacon cell targeting
[patent_app_type] => utility
[patent_app_number] => 17/594193
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 10480
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594193 | Localization of payload delivery systems to tumor sites via beacon cell targeting | Apr 7, 2020 | Issued |
Array
(
[id] => 17611500
[patent_doc_number] => 20220153779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => COMPOSITIONS AND METHODS FOR MODIFICATION OF TARGET MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/440129
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440129 | COMPOSITIONS AND METHODS FOR MODIFICATION OF TARGET MOLECULES | Mar 18, 2020 | Pending |
Array
(
[id] => 18064497
[patent_doc_number] => 20220395584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => REVERSIBLE COATING OF CHITOSAN-NUCLEIC ACID NANOPARTICLES AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/438921
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438921 | REVERSIBLE COATING OF CHITOSAN-NUCLEIC ACID NANOPARTICLES AND METHODS OF THEIR USE | Mar 12, 2020 | Pending |
Array
(
[id] => 18064497
[patent_doc_number] => 20220395584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => REVERSIBLE COATING OF CHITOSAN-NUCLEIC ACID NANOPARTICLES AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/438921
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438921 | REVERSIBLE COATING OF CHITOSAN-NUCLEIC ACID NANOPARTICLES AND METHODS OF THEIR USE | Mar 12, 2020 | Pending |
Array
(
[id] => 17593638
[patent_doc_number] => 20220143211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => HYDROGELS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/437579
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437579 | Hydrogels and methods of using the same | Mar 10, 2020 | Issued |